in this issue
Regions :: China
Evonik API site in China receives written confirmation of EU GMP compliance
11:24 AM MDT | October 28, 2013 | Deepti Ramesh
Evonik Industries says that it was one of the first active pharmaceutical ingredient (API)–producing companies in China to be granted written confirmations by the Guangxi Food and Drug Administration for all products manufactured at the company's site at Wuming, China. These confirmations certify that the facility operates in accordance with EU GMP requirements. As of 2 July, the compliance of APIs manufactured outside and imported into the EU must be confirmed in writing by a competent authority of the exporting country. This document must also...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee